- Home
- SIGA vs ACP Comparison
SIGA vs ACP Comparison
Compare SIGA & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- ACP
- Stock Information
- Founded
- SIGA 1995
- ACP 2010
- Country
- SIGA United States
- ACP United States
- Employees
- SIGA N/A
- ACP N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- ACP Investment Managers
- Sector
- SIGA Health Care
- ACP Finance
- Exchange
- SIGA Nasdaq
- ACP Nasdaq
- Market Cap
- SIGA 594.3M
- ACP 712.7M
- IPO Year
- SIGA 1997
- ACP N/A
- Fundamental
- Price
- SIGA $8.06
- ACP $5.50
- Analyst Decision
- SIGA
- ACP
- Analyst Count
- SIGA 0
- ACP 0
- Target Price
- SIGA N/A
- ACP N/A
- AVG Volume (30 Days)
- SIGA 349.5K
- ACP 337.9K
- Earning Date
- SIGA 11-10-2025
- ACP 01-01-0001
- Dividend Yield
- SIGA 7.38%
- ACP 17.79%
- EPS Growth
- SIGA N/A
- ACP N/A
- EPS
- SIGA 1.14
- ACP N/A
- Revenue
- SIGA $179,639,422.00
- ACP N/A
- Revenue This Year
- SIGA N/A
- ACP N/A
- Revenue Next Year
- SIGA $115.06
- ACP N/A
- P/E Ratio
- SIGA $7.14
- ACP N/A
- Revenue Growth
- SIGA 3.86
- ACP N/A
- 52 Week Low
- SIGA $4.95
- ACP $5.55
- 52 Week High
- SIGA $9.62
- ACP $7.17
- Technical
- Relative Strength Index (RSI)
- SIGA 40.69
- ACP 30.39
- Support Level
- SIGA $8.07
- ACP $5.53
- Resistance Level
- SIGA $8.54
- ACP $5.69
- Average True Range (ATR)
- SIGA 0.24
- ACP 0.06
- MACD
- SIGA -0.03
- ACP -0.01
- Stochastic Oscillator
- SIGA 11.01
- ACP 5.00
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.